10 Biotech Stocks With The Biggest Upside
In this article, we discuss the 10 biotech stocks with the biggest upside.
Ampio Pharmaceuticals Inc. (AMPE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.29 | 21,858 | Director | 146,858 | 2023-06-09 | Filing | |
| $0.30 | 25,000 | Director | 125,000 | 2023-06-08 | Filing | |
| $0.29 | 76,890 | Officer, Director | 76,890 | 2023-05-24 | Filing | |
| $0.27 | 32,534 | Director | 100,000 | 2023-05-16 | Filing | |
| $0.25 | 44,026 | Director | 67,466 | 2023-05-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.79 | 22,500 | 28,315 | 2021-06-25 | Filing | ||
| $2.00 | 2,603 | 0 | 2021-05-21 | Filing | ||
| $2.00 | 6,737 | 203,500 | 2021-05-21 | Filing | ||
| $1.83 | 35,000 | 28,315 | 2021-05-18 | Filing | ||
| $2.00 | 20,000 | 203,500 | 2021-04-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 289,600 | $593,680 | 0% | |
| 2. | 19,580 | $40,139 | 0% | |
| 3. | 11,700 | $23,985 | 0% | |
| 4. | 3,149 | $6,455 | 0% | |
| 5. | 2,757 | $5,652 | 0% |
News See All
13 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 13 best biotech penny stocks to buy now.
Here is What Hedge Funds Think About Ampio Pharmaceuticals, Inc. (AMPE)
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking.
AcelRx Pharmaceuticals Inc (ACRX): Insiders Are Buying, Should You?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a first-rate investment today? Hedge funds are getting less optimistic.
Regeneron Pharmaceuticals Inc (REGN): Is This Eye Drug Worth The Hype?
Editor’s Note: The original article incorrectly references Lucentis’ and Eylea’s dosage instructions and Roche's vaccine market share.
Regeneron Pharmaceuticals Inc (REGN): Is This Eye Drug Worth The Hype?
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) should spike– every time there’s a slight pullback the stock shoots higher.
Hedge Funds Are Betting On Horizon Pharma Inc (HZNP)
To most investors, hedge funds are seen as slow, old investment tools of years past.
Regeneron Pharmaceuticals Inc (REGN), Ampio Pharmaceuticals, Inc. (AMPE): Is This Eye Drug Worth The Hype?
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) should spike– every time there’s a slight pullback the stock shoots higher.
Hedge Funds Are Crazy About Zogenix, Inc. (ZGNX)
In today’s marketplace, there are a multitude of gauges shareholders can use to analyze the equity markets. Some of the most useful are hedge fund and insider trading movement.
Horizon Pharma Inc (HZNP): Insiders Are Dumping, Should You?
According to most shareholders, hedge funds are perceived as unimportant, old financial vehicles of yesteryear.